Eintrag weiter verarbeiten
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells
Gespeichert in:
Zeitschriftentitel: | Cancer Biology & Therapy |
---|---|
Personen und Körperschaften: | , , , |
In: | Cancer Biology & Therapy, 18, 2017, 7, S. 473-483 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Informa UK Limited
|
Schlagwörter: |
author_facet |
Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In |
---|---|
author |
Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In |
spellingShingle |
Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In Cancer Biology & Therapy Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells Cancer Research Pharmacology Oncology Molecular Medicine |
author_sort |
starenki, dmytro |
spelling |
Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In 1538-4047 1555-8576 Informa UK Limited Cancer Research Pharmacology Oncology Molecular Medicine http://dx.doi.org/10.1080/15384047.2017.1323594 Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells Cancer Biology & Therapy |
doi_str_mv |
10.1080/15384047.2017.1323594 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xNTM4NDA0Ny4yMDE3LjEzMjM1OTQ |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xNTM4NDA0Ny4yMDE3LjEzMjM1OTQ |
institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
imprint |
Informa UK Limited, 2017 |
imprint_str_mv |
Informa UK Limited, 2017 |
issn |
1555-8576 1538-4047 |
issn_str_mv |
1555-8576 1538-4047 |
language |
English |
mega_collection |
Informa UK Limited (CrossRef) |
match_str |
starenki2017vandetanibandcabozantinibpotentiatemitochondriatargetedagentstosuppressmedullarythyroidcarcinomacells |
publishDateSort |
2017 |
publisher |
Informa UK Limited |
recordtype |
ai |
record_format |
ai |
series |
Cancer Biology & Therapy |
source_id |
49 |
title |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_unstemmed |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_full |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_fullStr |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_full_unstemmed |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_short |
Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_sort |
vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
topic |
Cancer Research Pharmacology Oncology Molecular Medicine |
url |
http://dx.doi.org/10.1080/15384047.2017.1323594 |
publishDate |
2017 |
physical |
473-483 |
description |
|
container_issue |
7 |
container_start_page |
473 |
container_title |
Cancer Biology & Therapy |
container_volume |
18 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792339609548488707 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:49:45.886Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Vandetanib+and+cabozantinib+potentiate+mitochondria-targeted+agents+to+suppress+medullary+thyroid+carcinoma+cells&rft.date=2017-07-03&genre=article&issn=1555-8576&volume=18&issue=7&spage=473&epage=483&pages=473-483&jtitle=Cancer+Biology+%26+Therapy&atitle=Vandetanib+and+cabozantinib+potentiate+mitochondria-targeted+agents+to+suppress+medullary+thyroid+carcinoma+cells&aulast=Park&aufirst=Jong-In&rft_id=info%3Adoi%2F10.1080%2F15384047.2017.1323594&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792339609548488707 |
author | Starenki, Dmytro, Hong, Seung-Keun, Wu, Pui-Kei, Park, Jong-In |
author_facet | Starenki, Dmytro, Hong, Seung-Keun, Wu, Pui-Kei, Park, Jong-In, Starenki, Dmytro, Hong, Seung-Keun, Wu, Pui-Kei, Park, Jong-In |
author_sort | starenki, dmytro |
container_issue | 7 |
container_start_page | 473 |
container_title | Cancer Biology & Therapy |
container_volume | 18 |
description | |
doi_str_mv | 10.1080/15384047.2017.1323594 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xNTM4NDA0Ny4yMDE3LjEzMjM1OTQ |
imprint | Informa UK Limited, 2017 |
imprint_str_mv | Informa UK Limited, 2017 |
institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
issn | 1555-8576, 1538-4047 |
issn_str_mv | 1555-8576, 1538-4047 |
language | English |
last_indexed | 2024-03-01T15:49:45.886Z |
match_str | starenki2017vandetanibandcabozantinibpotentiatemitochondriatargetedagentstosuppressmedullarythyroidcarcinomacells |
mega_collection | Informa UK Limited (CrossRef) |
physical | 473-483 |
publishDate | 2017 |
publishDateSort | 2017 |
publisher | Informa UK Limited |
record_format | ai |
recordtype | ai |
series | Cancer Biology & Therapy |
source_id | 49 |
spelling | Starenki, Dmytro Hong, Seung-Keun Wu, Pui-Kei Park, Jong-In 1538-4047 1555-8576 Informa UK Limited Cancer Research Pharmacology Oncology Molecular Medicine http://dx.doi.org/10.1080/15384047.2017.1323594 Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells Cancer Biology & Therapy |
spellingShingle | Starenki, Dmytro, Hong, Seung-Keun, Wu, Pui-Kei, Park, Jong-In, Cancer Biology & Therapy, Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells, Cancer Research, Pharmacology, Oncology, Molecular Medicine |
title | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_full | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_fullStr | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_full_unstemmed | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_short | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_sort | vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
title_unstemmed | Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells |
topic | Cancer Research, Pharmacology, Oncology, Molecular Medicine |
url | http://dx.doi.org/10.1080/15384047.2017.1323594 |